GCI Health has announced the appointment of three senior roles on its UK management team, reporting to recently named president of Europe and Middle East, Kath Kerry.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh